Development of an arteriolar niche and self-renewal of breast cancer stem cells by lysophosphatidic acid/protein kinase D signaling
Beck, Adam W
Wang, Qiming Jane
MetadataShow full item record
AbstractBreast cancer stem cells (BCSCs) are essential for cancer growth, metastasis and recurrence. The regulatory mechanisms of BCSC interactions with the vascular niche within the tumor microenvironment (TME) and their self-renewal are currently under extensive investigation. We have demonstrated the existence of an arteriolar niche in the TME of human BC tissues. Intriguingly, BCSCs tend to be enriched within the arteriolar niche in human estrogen receptor positive (ER+) BC and bi-directionally interact with arteriolar endothelial cells (ECs). Mechanistically, this interaction is driven by the lysophosphatidic acid (LPA)/protein kinase D (PKD-1) signaling pathway, which promotes both arteriolar differentiation of ECs and self-renewal of CSCs likely via differential regulation of CD36 transcription. This study indicates that CSCs may enjoy blood perfusion to maintain their stemness features. Targeting the LPA/PKD-1 -CD36 signaling pathway may have therapeutic potential to curb tumor progression by disrupting the arteriolar niche and effectively eliminating CSCs.
breast cancer stem cells
Cell Self Renewal
Protein Kinase D
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16119
- Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling.
- Authors: Dong L, Yuan Y, Opansky C, Chen Y, Aguilera-Barrantes I, Wu S, Yuan R, Cao Q, Cheng YC, Sahoo D, Silverstein RL, Ren B
- Issue date: 2017 Apr 4
- Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
- Authors: Sehl ME, Shimada M, Landeros A, Lange K, Wicha MS
- Issue date: 2015
- LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.
- Authors: Ren B, Best B, Ramakrishnan DP, Walcott BP, Storz P, Silverstein RL
- Issue date: 2016 Jun
- The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147(+) breast cancer stem cells.
- Authors: Lv Y, Wang T, Fan J, Zhang Z, Zhang J, Xu C, Li Y, Zhao G, He C, Meng H, Yang H, Wang Z, Liu J, Chen J, Wang L
- Issue date: 2017 Apr
- Cancer stem cells (CSCs) in cancer progression and therapy.
- Authors: Najafi M, Farhood B, Mortezaee K
- Issue date: 2019 Jun